Filter
3333
Filtered Results: 3333
Text search:
medicine
product
Featured
Recommendations
300
New Publications
853
Language
Document type
No document type
1751
Studies & Reports
645
Guidelines
482
Manuals
182
Strategic & Response Plan
122
Training Material
63
Fact sheets
51
Situation Updates
23
Resource Platforms
7
Infographics
3
Brochures
2
App
1
Online Courses
1
Countries / Regions
Global
141
India
125
Kenya
104
Ethiopia
85
Nigeria
69
South Africa
68
Uganda
61
Nepal
61
Sierra Leone
56
Western and Central Europe
54
Tanzania
52
Latin America and the Carribbean
51
Malawi
50
Ghana
47
Myanmar / Burma
45
Bangladesh
44
Liberia
43
Zambia
43
Rwanda
42
Africa
42
Philippines
34
Zimbabwe
30
South–East Asia Region
29
Namibia
28
Ukraine
27
Syria
25
Lesotho
23
Congo, Democratic Republic of
19
East and Southern Africa
19
Asia
19
West and Central Africa
18
Eastern Europe
18
Senegal
17
Cambodia
17
Indonesia
17
Cameroon
16
Haiti
16
Germany
15
Mozambique
15
Middle East and North Africa
15
Burkina Faso
14
Guinea
13
Brazil
12
Thailand
11
Sudan
11
Botswana
11
South Sudan
10
Afghanistan
10
Eswatini/ Swaziland
10
Eastern Europe and Central Asia
10
Venezuela
10
USA
9
Pakistan
9
Benin
9
Yemen
9
Vietnam
9
China
8
Albania
7
Moldova
7
Jordan
6
Lebanon
6
Russia
6
Somalia
5
Peru
5
Colombia
5
Sri Lanka
5
Western Pacific Region
5
Laos
5
Tajikistan
5
Georgia
5
United Kingdom
5
Mali
4
Papua New Guinea
4
North Macedonia
4
Ecuador
4
Madagascar
4
Iran
4
Kyrgyzstan
4
Côte d’Ivoire / Ivory Coast
3
Turkey
3
Central African Republic
3
Argentina
3
Chile
3
Paraguay
3
Poland
3
Southern Africa
3
Timor Leste/ East Timor
3
Kazakhstan
3
North America
3
Jamaica
3
Japan
3
Morocco
2
Saudi Arabia
2
Iraq
2
Chad
2
Gambia
2
Malaysia
2
Hungary
2
Burundi
2
Bolivia
2
Libya
2
Angola
2
Mexico
2
Other region
2
Fiji
2
Estonia
2
Romania
2
Turkmenistan
2
Mauritius
2
Portugal
2
Spain
2
Bosnia and Herzegovina
2
Niger
1
Togo
1
Egypt
1
Serbia
1
Greece
1
Guatemala
1
Bhutan
1
Italy
1
Mongolia
1
Qatar
1
Bulgaria
1
Lithuania
1
Uzbekistan
1
Australia
1
Gabon
1
Denmark
1
France
1
Maldives
1
Tunisia
1
Norway
1
Belarus
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
1200
Clinical Guidelines
330
Public Health
218
Women & Child Health
159
Key Resources
116
Capacity Building
57
Pharmacy & Technologies
57
Toolboxes
COVID-19
245
Mental Health
221
AMR
220
HIV
201
TB
178
Planetary Health
151
Pharmacy
150
NTDs
105
Rapid Response
91
NCDs
77
Caregiver
71
Disability
70
Ebola
68
Conflict
61
Global Health Education
59
Refugee
34
Natural Hazards
32
Health Financing Toolbox
32
Specific Hazards
26
Zika
18
Cholera
10
Polio
10
Social Ethics
9
Health Financing
2
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, ... classes and formulations on the Model Lists of Essential Medicines. The Committee evaluated the scientific evidence for comparative effectiveness, safety and cost-effectiveness of the medicines in question. The Committee also considered a review of the therapeutic alternatives for medicines on the Model Lists, and update to the AWaRe classification of antibiotics, and reviews and reports relevant to the selection and use of essential medicines.
The aim of these Guidelines is to provide a framework for the conservation and sustainable use of plants in medicine. To do this, the Guidelines describe the various tasks that should be carried out to ensure that where medicinal plants are taken fr...
This report explores the reasons why global health is critical to medicine and what this means for medical education. It argues that an understanding of global health is important for all students and practicing doctors, rather than being an ‘add-...
Building on our decades of commitment to human rights in medicine and healthcare, we have published a new report on emerging threats in health-related human rights both globally and in the UK.
'Health and human rights in the new world (dis)order'...
These guidelines have been developed to provide guidance to the Ministry of Health in managing applications for registration of human pharmaceutical products in Rwanda. It was compiled by the Technical Working Group (TWG) on Medicines Evaluation and...
This action plan for the Kingdom Saudi Arabia to combat antimicrobial resistance has been formulated in the line of the WHO five objectives. It addresses the need for effective “one health” approach involving coordination among numerous national sectors and actors, including human and veterinary...
This World Health Organization (WHO) and the International Labour Organization (ILO) joint guidelines production aims at harnessing the contribution of employers and workers towards the control of TB. It covers all the practical steps involved in es...
Ethiopia GATS was implemented by Ethiopia Public Health Institute (EPHI) in collaboration with the Ethiopian Food, Medicine, Health Care Administration and Control Authority (FMHACA), CSA, FMOH and the World Health Orga...
The project will support preventive actions, traditional medicine and the coordination and
implementation capacities of the national framework for HIV/AIDS control.
Exciting new treatment approaches make the management of hepatitic C one of the most rapidly developing areas of medicine. The Flying Publisher short Guide to Hepatitis C is an up-to-date source of information for physicians, residents and advanced ...
This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicine safety systems.
Irresponsible pharmaceutical companies fuel the proliferation of superbugs through supply chain pollution, the European Public Health Alliance (EPHA) reports. The advocacy group uncovered lapses such as dirty production and inadequate waste disposal...
The guidelines reiterate that the general principles of ethics for biomedical research involving human participants shall also be applicable. In addition, the guidelines specify unique provisions for stem cells, because of their inherent property for unlimited proliferation, differentiation to cells...
The objective of this report is to assess the situational landscape during mid-May 2020 surrounding the value chain of the production and distribution of generic antiretroviral medicines in low- and-middle-income countries and to provide recommendat...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD ..., and service delivery.
Digital health technologies can help address these challenges. They may be a tool
to reach Sustainable Development Goal 3.4 and reduce premature mortality from
non-communicable diseases (NCDs) by a third by 2030. Yet, a range of fundamental barriers prevents implementation and access to such technologies. Health system governance, health provider, patient and technological factors can prevent or distort their implementation.
World Heart Federation (WHF) roadmaps aim to identify essential roadblocks on the pathway to effective prevention, detection, and treatment of CVD. Further, they aim to provide actionable solutions and implementation frameworks for local adaptation. This WHF Roadmap for digital health in cardiology identifies barriers to implementing digital health technologies for CVD and provides recommendations for overcoming them.
This paper focuses on the Sustainable Development Goals related to poverty, economic growth, inequality, health, food production and the environment. It presents concrete examples of the underlying and complex aspects of antibiotic resistance and it...
Antimicrobial resistance (AMR) is a threat to human and animal health and refers to the ability of microorganisms to defy the medicines prescribed. For instance when antibiotics are used improperly, such as an incorrect dose, insufficient duration or wrong frequency, resistance is heightened. The mi...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
Noncommunicable diseases (NCDs) such as cancer, cardiovascular diseases, diabetes and chronic respiratory diseases and their risk factors are an increasing public health and development challenge in Turkey. This report provides evidence through three analyses that NCDs reduce economic output, and di...
